These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35337642)

  • 1. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study.
    Närhi F; Moonesinghe SR; Shenkin SD; Drake TM; Mulholland RH; Donegan C; Dunning J; Fairfield CJ; Girvan M; Hardwick HE; Ho A; Leeming G; Nguyen-Van-Tam JS; Pius R; Russell CD; Shaw CA; Spencer RG; Turtle L; Openshaw PJM; Baillie JK; Harrison EM; Semple MG; Docherty AB;
    Lancet Digit Health; 2022 Apr; 4(4):e220-e234. PubMed ID: 35337642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
    Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
    Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK.
    Docherty AB; Mulholland RH; Lone NI; Cheyne CP; De Angelis D; Diaz-Ordaz K; Donegan C; Drake TM; Dunning J; Funk S; García-Fiñana M; Girvan M; Hardwick HE; Harrison J; Ho A; Hughes DM; Keogh RH; Kirwan PD; Leeming G; Nguyen Van-Tam JS; Pius R; Russell CD; Spencer RG; Tom BD; Turtle L; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
    Lancet Respir Med; 2021 Jul; 9(7):773-785. PubMed ID: 34000238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study.
    Turtle L; Elliot S; Drake TM; Thorpe M; Khoury EG; Greenhalf W; Hardwick HE; Leeming G; Law A; Oosthuyzen W; Pius R; Shaw CA; Baillie JK; Openshaw PJM; Docherty AB; Semple MG; Harrison EM; Palmieri C;
    Lancet Oncol; 2024 May; 25(5):636-648. PubMed ID: 38621404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19.
    Camirand-Lemyre F; Merson L; Tirupakuzhi Vijayaraghavan BK; Burrell AJC; Citarella BW; Domingue MP; Lévesque S; Usuf E; Wils EJ; Ohshimo S; Martin-Loeches I; Sandulescu O; Laake JH; Lamontagne F;
    JAMA Netw Open; 2023 Dec; 6(12):e2346502. PubMed ID: 38147336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials.
    Sterne JAC; Diaz J; Villar J; Murthy S; Slutsky AS; Perner A; Jüni P; Angus DC; Annane D; Azevedo LCP; Du B; Dequin PF; Gordon AC; Green C; Higgins JPT; Horby P; Landray MJ; Lapadula G; Le Gouge A; Leclerc M; Savović J; Tomazini B; Venkatesh B; Webb S; Marshall JC;
    Trials; 2020 Aug; 21(1):734. PubMed ID: 32831155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
    Drake TM; Riad AM; Fairfield CJ; Egan C; Knight SR; Pius R; Hardwick HE; Norman L; Shaw CA; McLean KA; Thompson AAR; Ho A; Swann OV; Sullivan M; Soares F; Holden KA; Merson L; Plotkin D; Sigfrid L; de Silva TI; Girvan M; Jackson C; Russell CD; Dunning J; Solomon T; Carson G; Olliaro P; Nguyen-Van-Tam JS; Turtle L; Docherty AB; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
    Lancet; 2021 Jul; 398(10296):223-237. PubMed ID: 34274064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and intensive care unit admission in patients with COVID-19 according to patients' oxygen requirements.
    Tortajada C; Colomer E; Andreu-Ballester JC; Esparcia A; Oltra C; Flores J
    J Med Virol; 2021 Mar; 93(3):1817-1823. PubMed ID: 33107607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit.
    Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O
    J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic corticosteroids for the treatment of COVID-19.
    Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study.
    Hyams JS; Davis S; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo P; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis A; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Britt A; Saul B; Gotman N; Wang J; Serrano J; Kugathasan S; Walters T; Denson LA
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):855-868. PubMed ID: 28939374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a Target Trial Emulation Framework vs Cox Regression to Estimate the Association of Corticosteroids With COVID-19 Mortality.
    Hoffman KL; Schenck EJ; Satlin MJ; Whalen W; Pan D; Williams N; Díaz I
    JAMA Netw Open; 2022 Oct; 5(10):e2234425. PubMed ID: 36190729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
    Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
    Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Systemic Corticosteroids on Mortality in Older Adults With Critical COVID-19 Pneumonia.
    Piniella-Ruiz E; Bellver-Álvarez MT; Mestre-Gómez B; Escolano-Fernández B; Vinat-Prado S; Cabezas-Olea R; Acedo-Gutiérrez MS; Akasbi-Montalvo M; Ryan-Murua P; Bustamante-Fermosel A; Muñoz-Rivas N; Santamaría-García C; Pardo-Guimerá V; Ulla-Anés M; Franco-Moreno A; Torres-Macho J
    J Gerontol A Biol Sci Med Sci; 2021 Jul; 76(8):e127-e132. PubMed ID: 33711156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?
    FakhriRavari A; Jin S; Kachouei FH; Le D; Lopez M
    Int J Immunopathol Pharmacol; 2021; 35():20587384211063976. PubMed ID: 34923856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of corticosteroids in hospitalised COVID-19 patients.
    Ho KS; Narasimhan B; Difabrizio L; Rogers L; Bose S; Li L; Chen R; Sheehan J; El-Halabi MA; Sarosky K; Wang Z; Eisenberg E; Powell C; Steiger D
    BMJ Open Respir Res; 2021 Apr; 8(1):. PubMed ID: 33811098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.